NCT01583244View on ClinicalTrials.gov

Korean Post-marketing Surveillance for Orencia®

CompletedOBSERVATIONAL
Enrollment

701

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
Rheumatoid Arthritis
Interventions
DRUG

No Intervention (subjects were previously treated with Orencia®)

No Intervention

Trial Locations (1)

110-756

Local Institution, Seoul

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY